Member Info for Thelix

USA is where it is at. Nothing to do with EU. Everything has gone down and this will pick back up. Calm down.

OXP didn't rely on any EU money and this is generic drugs that have been tested - it is the formulation that is different, and has been tested as safe. We're not releasing new weird and wonderful compounds. We're repackaging the NSAID's market with a formulation that decreases side effects allowing millions more who suffer from them to take NSAID's. I don't see how it materially affects OXP - but the markets are what they are, confidence driven, without much actual truth or fact to support it, which is why sharp drops and bounces happen in our economies these days.

Probably yes. Not for any legitimate reason other than short term market volatility. Let the magic numbers on the screen do their silly dance and once everyone calms down and realises even if we do exit, that it isn't for another 2 years minimum and everything is as per 22nd June in terms of us being in the EU, when it will recover.

go down the road of personal portfolios therefore panic or not panic. VRP has now been fully funded, and will be going through IPO procedures, including a NASDAQ listing. VRP has excellent clinical trial results that should pass Phase 3 even if they perform worse than the Phase 2's (VERY low p value!) We also have the benefit of COPD being a very obvious disease, with placebo having almost no effect, meaning 554 should always achieve excellent results. It has no side effects or minimal, and is toxicity free. There may be some dilution, there may be some red days, but given our buy in prices are £35 mil MCAP approx, in an industry that can make hundreds of millions at commercial, and potentially a billion or two if the platform increases in scope worldwide, I am very very happy to have a considerable holding here.

No set dates from my knowledge. It will more than likely be done when price is much higher to raise funds for phase 3 once the phase 2's go well. Again just my assessment from previous experience. Still approximate guesswork.

It might be brexit fears. Especially if this has a German listing too. I also think many still don't understand why this placing is different to others. Extra listings, raising cash to progress clinical phases with partner prospects and ii's wanting a slice of cake and non execs being formed. This is the first stage transformation of the company going from R&D to proper clinical stages with real impact. 2nd transformation will be phase 3 and NDA filing. Then commercial. I will be buying and selling in those stages as they will have a "waning" effect between each one. This is all just my (very educated) opinion.

The placing has yet to go ahead so resistance at those levels will be had and it cant shoot much above. I am awaiting the NASDAQ listing where this will go beserk.

Thats just business. Making drugs is very costly. Its not nice when life saving medicine costs lots, or when pharma report massive profits. But it does cost a lot, and as we have seen - some formulations fail despite money spent to make them and put them on trial etc. I genuinely dont think we need to hold very longterm for the rise. Once on nasdaq I can see this easily reaching 10p within months. the IPO alone will bag this, where I will admit I shall sell. Then once the phase 3 risk is over ill buy back in for commercial profits

This isnt a regular placing. It is effectively adding shares to another listing while simultaneously raising a lot of cash. This isnt some AIM placing where they forward sell a mil or two. This is properly set out longterm investments. This is only going one way so long as the clinical trials come through good. It may drop in the meantime but Id argue its not likely to drop much or for long.

42020 shares for me @ 3.54. Gonna sit on this now, already held a few k prior to this news.

whether you hold a US ADS, or a european share. It all ends up the same after the currency conversion. The price will fluctuate wildly and may even go down, but once this is on nasdaq, BOOM.

You have to look at whats happened. Commercial sales of NIOX is in millions - not much, and the latest pipeline model just failed while working at a monetary loss. Further pipeline down the road but realistically 1 year + before anything noteworthy. Either hold or wait for lower entry. The good news is they got massive funding last year and have a lot of cash to work with. But this probably will slip more IMPO. Good for anyone looking for a nice buy in price. Mine is 70-80p. Not saying it will go down that low, but thats the max Ill pay for it.

Are all about US sales. Europe talks of hundreds of millions or a few billion. America talks of hundreds of billions. The entire markets have been aritifically shafted with this brexit nonsense. Billions wiped from the FTSE and the results aren't even in. It's just people hedging. It'll all pop back up. I am licking my lips looking at all the cheap entries on so many companies! Excellent buying opportunity this brexit referendum is giving us!

when every post you have ever made is how bad something is. This has risen 80% from 4p figures. It is all relative. Those who put 3-4k in at the 4p mark are now seeing a few grand profit, and it is holding stable. OXP have already raised cash and it has stated it raised enough to progress all the way through to registering the drugs themselves without a commercial partner if they cant get one. They more than likely will get one given their results. This will not be sticking around sub 10p for long. Obviously neither of us know the future, but this share moves erratically and differently than the usual P&D shares. We saw it ourselves when it turned blue within an hour of a severe drop - which may I point out I did call. I did say if sp dives it will recover quickly - which it did. Nothing moves in a straight upwqrd trajectory in this game. We are going through consolidation of the 7's. Not even a retrace as highest ask so far has been 8p and is now 7.5p. Blip levels of red -not even retracing. Give it some time and we will be over 10p again.

I work in the pharma industry - the fundamentals ate very very good here and the company is being run like clockwork to keep costs down considerably. All but 1 trial passed easily with the 1 only lagging behind a few % needed. You have no clue.

You sign up, **** off OXP, and then call it completely wrong. Not interested. All your posts, all 17 of them, are negative. I myself am a conservative PI and like to control flights of fancy on message boards, but you're just pessimistic to a fault. I have ridden the OXP train from 4-5p to 12p before. I know how this thing moves. Obviously I cannot tell the future but this is going places medium/longterm.

might be interesting prior to presentation but I think Thursday might be a more interesting day this week. Will this week get us to 10p+? This can rise that quickly! Done it before and can do it again.

already stated nothing new, but OXP is still under the radar so it will help spotlight us somewhat.

Who got mugged today? Got so close to my original 6p mark I decided to have a cheeky top up. Again, this is only going one way medium/longterm. Previous holders on the last move to 12p know this moves erratically with minimal volume - this is just how OXP moves! Plenty of time for a 3 bagger from here minimum IMHO.

many got robbed today. Hold on tight this is only going one way longterm!